Recombinant Chlamydophila caviae Heat-inducible transcription repressor HrcA (hrcA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: While we will prioritize shipping the format currently in stock, please specify any format requirements in your order notes for customized preparation.

Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.

The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize development of the specified tag.

Synonyms
hrcA; CCA_00243Heat-inducible transcription repressor HrcA
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-386
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chlamydophila caviae (strain GPIC)
Target Names
hrcA
Target Protein Sequence
MSRSWISKRE SKILYILLTT TELYLKTGHP VGSKTLKEYE GSNLSTATIR NYFSELEAEG FLKKNHISGG RIPTDLAFRY YVDHCADCSQ DELPESTINL LNQLPEESQN IVKDLQKASE LLGEALQLPT CFSSPRFDND SVTNIQLSLV DEQRAVVILS TEFGQIFTDT LWLSEASNPA SLKRIEIFLQ SYVRKQSPME ILSQKEEDIG MTLYNEVVVR YLTRYCNFSE EDLYQTGLSK LLRYESFKDP DMLALGLSFF ENRRHMCKLL DIGMHRDRPT AFIGNELSDI FRTPNPQCAV ITIPYYMNRT PLGAFGVLGP VNLPYKEIFK TLTIFADKIK ASLTQSFYKF KLSFRRPCPS DPTLSKEPTL LARYSSIKLL PPKETS
Uniprot No.

Target Background

Function

Negative regulator of class I heat shock genes (grpE-dnaK-dnaJ and groELS operons). Prevents heat-shock induction of these operons.

Database Links
Protein Families
HrcA family

Q&A

What is HrcA and what is its primary function in bacterial cells?

HrcA is a heat-inducible transcriptional repressor that regulates bacterial heat shock gene expression. It functions as a negative regulator of transcription by binding to a cis-acting DNA element called CIRCE (Controlling Inverted Repeat of Chaperone Expression) . The HrcA-CIRCE system operates as a repressor-operator pair, where HrcA binds to the CIRCE element to prevent RNA polymerase from binding to heat shock promoters through steric hindrance, resulting in the repression of heat shock genes .

In normal conditions, HrcA actively represses heat shock genes such as the groE and dnaK operons, which encode chaperone proteins that protect cellular proteins from denaturation. During heat stress, HrcA's repressor activity is reduced, allowing for increased expression of these heat shock genes . This regulatory mechanism has been identified in over 40 eubacterial species, typically in association with groE or dnaK heat shock operons .

How does the structure of HrcA relate to its function?

The crystal structure of HrcA from Thermotoga maritima, resolved at 2.2Å resolution, provides valuable insights into the protein's functional domains. The HrcA monomer consists of three distinct domains:

  • An N-terminal winged helix-turn-helix domain (WH) - responsible for DNA binding

  • A GAF-like domain - involved in regulatory functions

  • An inserted dimerizing domain (IDD) - facilitates dimerization through hydrophobic contacts

The crystal structure implies that conformational changes are required for HrcA to transition from its inactive to active state, potentially through interactions with chaperones like GroEL that bind to conserved C-terminal sequences of HrcA . This structural plasticity likely allows HrcA to function as a thermosensor that responds to cellular stress conditions.

What is known about chlamydial HrcA specifically?

Chlamydial HrcA has several distinctive features compared to HrcA proteins from other bacterial species. Most notably, Chlamydia trachomatis HrcA contains a unique C-terminal tail that appears to serve as an inhibitory region . This C-terminal region significantly reduces the ability of HrcA to bind to its CIRCE operator and to repress transcription.

In vitro studies have demonstrated that full-length recombinant chlamydial HrcA has a lower binding affinity for CIRCE compared to a truncated form lacking the C-terminal tail. The difference is striking - the apparent dissociation constant (K) was calculated at 49 nM for full-length HrcA versus 0.89 nM for truncated HrcA, representing a >50-fold difference in binding affinity . Similarly, while full-length recombinant HrcA showed minimal repressor activity in in vitro transcription assays, the truncated form decreased dnaK transcription in a concentration-dependent manner by up to 10-fold .

Interestingly, when isolated from chlamydiae, endogenous HrcA demonstrated a higher binding affinity for CIRCE than recombinant HrcA, suggesting post-translational modifications or interactions with other factors in the chlamydial cell that enhance its function .

How does the C-terminal tail of chlamydial HrcA regulate its function?

The C-terminal tail of chlamydial HrcA serves as an inhibitory region that significantly modulates the protein's repressor activity. In vitro binding studies revealed that full-length recombinant HrcA has an apparent dissociation constant (K) of 49 nM for the CIRCE operator, while a truncated form lacking the C-terminal tail has a K value of 0.89 nM - demonstrating that the C-terminal region reduces binding affinity by over 50-fold .

This inhibitory effect extends to transcriptional repression as well. When tested in an in vitro transcription assay using the C. trachomatis dnaK promoter (which contains a CIRCE operator), full-length recombinant HrcA failed to repress transcription even at concentrations as high as 280 nM. In contrast, the truncated form of HrcA decreased dnaK transcription in a concentration-dependent manner, achieving up to 10-fold repression at 100 nM .

Researchers have observed that the heat shock protein GroEL counteracts the inhibitory effect of the C-terminal tail. When GroEL was added to in vitro assays, it enhanced HrcA's ability to bind CIRCE and repress transcription, with a greater stimulatory effect on full-length HrcA than on the truncated form . This supports a model in which GroEL functions as a corepressor that interacts with HrcA, particularly with its C-terminal region, to modulate chlamydial heat shock gene expression in response to cellular conditions.

What is the relationship between HrcA and chaperone proteins like GroEL?

The relationship between HrcA and the chaperone protein GroEL represents a sophisticated feedback regulatory mechanism in bacterial heat shock response. Evidence indicates that GroEL functions as a corepressor that interacts with HrcA to enhance its ability to bind to the CIRCE operator and repress transcription of heat shock genes .

This interaction is particularly significant for chlamydial HrcA, where GroEL has been shown to counteract the inhibitory effect of the unique C-terminal tail. In in vitro studies, GroEL enhanced the ability of HrcA to bind CIRCE and to repress transcription, with a more pronounced stimulatory effect on full-length HrcA compared to HrcA lacking the C-terminal tail .

The structural implications of this interaction have been discussed in the context of the HrcA crystal structure from Thermotoga maritima. Researchers have suggested that the inactive form of HrcA observed in the crystal structure may be converted to an active form through GroEL binding to a conserved C-terminal sequence region of HrcA . This would represent a direct mechanism by which chaperone levels in the cell could modulate HrcA activity.

This regulatory feedback loop makes biological sense: under normal conditions, GroEL would be available to interact with HrcA, enhancing its repressor activity and maintaining low levels of heat shock gene expression. During heat stress, GroEL would be predominantly engaged with denatured proteins, becoming unavailable to interact with HrcA, thus reducing HrcA's repressor activity and allowing increased expression of heat shock genes .

How does HrcA contribute to the heat shock response in Chlamydia despite limited transcriptional machinery?

Chlamydia trachomatis presents an interesting model for studying heat shock response because it has a remarkably streamlined genome encoding only three sigma factors and a single heat-induced transcription factor (HrcA), yet exhibits a robust heat shock response . Transcriptomic analyses have revealed that nearly one-third of C. trachomatis genes showed statistically significant (≥1.5-fold) expression changes 30 minutes after shifting from 37°C to 45°C .

The chlamydial heat shock response involves several coordinated strategies:

  • Upregulation of genes encoding chaperones to facilitate protein folding

  • Increased expression of energy metabolism enzymes to boost energy production

  • Enhanced expression of type III secretion proteins to manipulate host activities

  • Upregulation of plasmid-encoded genes

  • Downregulation of genes involved in protein synthesis

HrcA plays a critical role in this response through its interaction with CIRCE elements. Heat shock relieves the negative regulation by HrcA, allowing increased expression of heat shock proteins. Interestingly, heat shock also affects sigma factor expression in C. trachomatis, upregulating the primary sigma factor σ66 and an alternative sigma factor σ28, while downregulating another alternative sigma factor σ54 .

The downregulation of σ54 is accompanied by increased expression of the σ54 RNA polymerase activator AtoC, suggesting a unique regulatory mechanism for reestablishing normal expression of select σ54 target genes . This complex interplay between HrcA and sigma factors enables C. trachomatis to mount an effective heat shock response despite its limited transcriptional machinery.

What experimental approaches are most effective for studying HrcA-DNA interactions?

Several experimental approaches have proven effective for studying HrcA-DNA interactions, with electrophoretic mobility shift assays (EMSAs) being particularly valuable. Researchers have successfully used EMSAs to demonstrate that purified recombinant HrcA binds specifically to the CIRCE element in a concentration-dependent manner .

In preparing recombinant HrcA for such studies, researchers have encountered challenges due to premature translational termination in E. coli expression systems. This issue arises from tandem rare arginine codons (AGA-AGA) at positions 361-362 in the C. trachomatis hrcA sequence. By replacing these codons with silent mutations (CGT-CGC), researchers were able to produce full-length recombinant HrcA . This codon optimization strategy may be necessary when working with recombinant chlamydial proteins in E. coli expression systems.

For studying HrcA's repressor function, in vitro transcription assays using promoters containing CIRCE elements (such as the dnaK promoter) have been successfully employed . These assays have revealed that transcriptional repression by HrcA may be dependent on the topological state of the promoter, as repression on a supercoiled promoter template was greater than that on a linearized template .

Additionally, structural studies using X-ray crystallography have provided valuable insights into the domain organization and potential regulatory mechanisms of HrcA . These approaches, combined with site-directed mutagenesis to examine specific functional regions, offer a comprehensive toolkit for investigating HrcA function across different bacterial species.

What strategies can improve the expression of full-length recombinant chlamydial HrcA?

When expressing chlamydial HrcA in heterologous systems like E. coli, researchers have encountered challenges with premature translational termination. This occurs due to tandem rare arginine codons (AGA-AGA) at positions 361-362 in the C. trachomatis hrcA sequence, which can cause truncated protein products to form .

To address this issue, codon optimization strategies have proven effective. Specifically, replacing the tandem AGA codons with the silent mutations CGT-CGC allowed researchers to produce full-length recombinant HrcA without truncation artifacts . This optimization considers that AGA is a rare codon in E. coli but not in Chlamydia, highlighting the importance of codon usage analysis when expressing chlamydial proteins in heterologous systems.

Additionally, using appropriate expression vectors with purification tags (such as six-His tags) has facilitated the efficient purification of recombinant HrcA . The pRSET-C expression vector has been successfully used for cloning and expressing chlamydial hrcA, providing a useful starting point for researchers working with this protein .

How can the functional activity of purified recombinant HrcA be assessed?

Multiple complementary approaches have been employed to assess the functional activity of purified recombinant HrcA:

  • DNA-binding assays: Electrophoretic mobility shift assays (EMSAs) provide a straightforward method to demonstrate that purified HrcA binds specifically to CIRCE elements. These assays can assess binding affinity by calculating apparent dissociation constants and can evaluate binding specificity through competition experiments with specific and non-specific DNA fragments .

  • In vitro transcription assays: These assays directly assess HrcA's ability to function as a transcriptional repressor. Using promoters that contain CIRCE elements (such as the dnaK promoter), researchers can measure how HrcA affects transcription levels. Such assays have revealed that repression is promoter-specific and may be dependent on the topological state of the DNA template .

  • Protein-protein interaction assays: Given the important regulatory interaction between HrcA and chaperones like GroEL, techniques to assess these interactions provide valuable functional insights. Both co-immunoprecipitation approaches and in vitro binding assays can demonstrate how GroEL enhances HrcA's repressor activity .

  • Structural analysis: Techniques like circular dichroism spectroscopy can assess whether recombinant HrcA is properly folded, while size exclusion chromatography can confirm its oligomeric state (typically dimeric, as observed in the crystal structure) .

Together, these approaches provide a comprehensive assessment of recombinant HrcA's functional characteristics, verifying both its DNA-binding and transcriptional repression activities.

How does chlamydial HrcA differ from HrcA in other bacterial species?

The most distinctive feature of chlamydial HrcA is its unique C-terminal tail, which functions as an inhibitory region not found in HrcA proteins from other bacterial species. This C-terminal extension significantly reduces the protein's ability to bind to CIRCE elements and repress transcription .

Unlike many other bacterial species, Chlamydia has adapted its heat shock response to function with limited transcriptional machinery. While most bacteria employ specialized sigma factors (like σ32 in E. coli) to regulate heat shock genes, Chlamydia lacks these specialized factors and relies more heavily on the HrcA-CIRCE system . This may explain the evolution of the unique regulatory features observed in chlamydial HrcA.

How is HrcA involved in Chlamydia pathogenesis and survival under stress conditions?

HrcA plays a crucial role in Chlamydia's ability to survive under stress conditions, which is particularly important for this obligate intracellular pathogen. Transcriptomic analyses have shown that heat shock in C. trachomatis leads to differential expression of nearly one-third of its genes, with significant upregulation of genes encoding chaperones, energy metabolism enzymes, and type III secretion proteins .

For Chlamydia, which has a biphasic developmental cycle alternating between infectious elementary bodies (EBs) and replicative reticulate bodies (RBs), the ability to respond to environmental stresses is critical for survival and transmission. The heat shock response regulated by HrcA is likely important during transitions between hosts and during inflammatory responses within a host.

Chlamydial infections are associated with various diseases in both humans and animals. C. trachomatis is a major cause of sexually transmitted infections and can lead to serious sequelae including pelvic inflammatory disease (PID), ectopic pregnancy, and tubal factor infertility . The ability of Chlamydia to persist and cause chronic infections may be linked to stress response mechanisms, including those regulated by HrcA.

The table below summarizes some of the Chlamydiaceae species, their primary hosts, and associated diseases:

SpeciesPrimary HostDiseases in Primary HostTransmission to Human
C. abortusSmall ruminants (sheep, goats)Abortion in late gestation or deliver weak/dead fetusPossible through close contact with infected tissues; causes abortion, stillbirth, gestational septicaemia, PID, and atypical pneumonia
C. aviumAvian (pigeons, psittacine birds)Respiratory diseaseUnknown
C. caviaeGuinea pigs, cats, dogs, rabbits, horsesConjunctivitis and urogenital tract infectionsPossible through close contact; causes mild conjunctivitis, severe community-acquired pneumonia
C. trachomatisHumansSexually transmitted infections, ocular infectionsN/A - human pathogen

Understanding how HrcA regulates the stress response in these different Chlamydia species may provide insights into their host adaptation and pathogenic potential .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.